Literature DB >> 25633137

Comparison of Ray Tracing and Monte Carlo Calculation Algorithms for Thoracic Spine Lesions Treated With CyberKnife-Based Stereotactic Body Radiation Therapy.

Christian C Okoye1, Ravi B Patel1, Shaakir Hasan2, Tarun Podder1, Anton Khouri1, Jeffrey Fabien1, Yuxia Zhang1, Donald Dobbins1, Jason W Sohn1, Jiankui Yuan1, Min Yao1, Mitchell Machtay1, Andrew E Sloan3, Jonathan Miller3, Simon S Lo4.   

Abstract

Stereotactic body radiation therapy (SBRT) is an emerging technology for the treatment of spinal metastases, although the dosimetric impact of the calculation method on spinal dose distribution is unknown. This study attempts to determine whether CyberKnife (CK)-based SBRT using a Ray Tracing (RyTc) algorithm is comparable dosimetrically to that of Monte Carlo (MC) for thoracic spinal lesions. Our institutional CK-based SBRT database for thoracic spinal lesions was queried and a cohort was generated. Patients were planned using RyTc and MC algorithms using the same beam angles and monitor units. Dose-volume histograms of the planning target volume (PTV), spinal cord, esophagus, and skin were generated, and dosimetric parameters were compared. There were 37 patients in the cohort. The average percentage volume of PTV covered by the prescribed dose with RyTc and MC algorithms was 91.1% and 80.4%, respectively (P < .001). The difference in average maximum spinal cord dose between RyTc and MC plans was significant (1126 vs 1084 cGy, P = .004), with the MC dose ranging from 18.7% below to 13.8% above the corresponding RyTc dose. A small reduction in maximum skin dose was also noted (P = .017), although no difference was seen in maximum esophageal dose (P = .15). Only PTVs smaller than 27 cm(3) were found to correlate with large (>10%) changes in dose to 90% of the volume (P = .014), while no correlates with the average percentage volume of PTV covered by the prescribed dose were demonstrated. For thoracic spinal CK-based SBRT, RyTc computation may overestimate the MC calculated average percentage volume of PTV covered by the prescribed dose and have unpredictable effects on doses to organs at risk, particularly the spinal cord. In this setting, use of RyTc optimization should be limited and always verified with MC.
© The Author(s) 2015.

Entities:  

Keywords:  Monte Carlo; Ray Tracing; inhomogeneous tissue density; lung–tumor interface; stereotactic body radiation therapy

Mesh:

Year:  2015        PMID: 25633137     DOI: 10.1177/1533034614568026

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  7 in total

1.  A phase I/II study on stereotactic body radiotherapy with real-time tumor tracking using CyberKnife based on the Monte Carlo algorithm for lung tumors.

Authors:  Hiromitsu Iwata; Satoshi Ishikura; Taro Murai; Michio Iwabuchi; Mitsuhiro Inoue; Koshi Tatewaki; Seiji Ohta; Naoki Yokota; Yuta Shibamoto
Journal:  Int J Clin Oncol       Date:  2017-04-20       Impact factor: 3.402

2.  A dosimetric parameter to limit chest wall toxicity in SABR of NSCLC.

Authors:  Raphaël Jumeau; Édith Filion; Houda Bahig; Toni Vu; Louise Lambert; David Roberge; Robert Doucet; Marie-Pierre Campeau
Journal:  Br J Radiol       Date:  2017-06-07       Impact factor: 3.039

3.  Treatment planning for spinal radiosurgery : A competitive multiplatform benchmark challenge.

Authors:  Christos Moustakis; Mark K H Chan; Jinkoo Kim; Joakim Nilsson; Alanah Bergman; Tewfik J Bichay; Isabel Palazon Cano; Savino Cilla; Francesco Deodato; Raffaela Doro; Jürgen Dunst; Hans Theodor Eich; Pierre Fau; Ming Fong; Uwe Haverkamp; Simon Heinze; Guido Hildebrandt; Detlef Imhoff; Erik de Klerck; Janett Köhn; Ulrike Lambrecht; Britta Loutfi-Krauss; Fatemeh Ebrahimi; Laura Masi; Alan H Mayville; Ante Mestrovic; Maaike Milder; Alessio G Morganti; Dirk Rades; Ulla Ramm; Claus Rödel; Frank-Andre Siebert; Wilhelm den Toom; Lei Wang; Stefan Wurster; Achim Schweikard; Scott G Soltys; Samuel Ryu; Oliver Blanck
Journal:  Strahlenther Onkol       Date:  2018-05-25       Impact factor: 3.621

Review 4.  Stereotactic body radiotherapy for benign spinal tumors: Meningiomas, schwannomas, and neurofibromas.

Authors:  Lindsay Hwang; Christian C Okoye; Ravi B Patel; Arjun Sahgal; Matthew Foote; Kristin J Redmond; Christoph Hofstetter; Rajiv Saigal; Mahmud Mossa-Basha; William Yuh; Nina A Mayr; Samuel T Chao; Eric L Chang; Simon S Lo
Journal:  J Radiosurg SBRT       Date:  2019

5.  Comparison of Ray Tracing and Monte Carlo Calculation Algorithms for Spine Lesions Treated With CyberKnife.

Authors:  Jun Li; Xile Zhang; Yuxi Pan; Hongqing Zhuang; Ruijie Yang
Journal:  Front Oncol       Date:  2022-05-04       Impact factor: 5.738

6.  Comparing the clinical outcomes in stereotactic body radiotherapy for lung tumors between Ray-Tracing and Monte-Carlo algorithms.

Authors:  Jin Ho Song; Ki Mun Kang; Hoon-Sik Choi; Hojin Jeong; In Bong Ha; Jong Deog Lee; Ho Cheol Kim; Yi Yeong Jeong; Yu Ji Cho; Seung Jun Lee; Sung Hwan Kim; In-Seok Jang; Bae Kwon Jeong
Journal:  Oncotarget       Date:  2016-04-05

7.  Local failure and vertebral body fracture risk using multifraction stereotactic body radiation therapy for spine metastases.

Authors:  Nihaal Mehta; Peter J Zavitsanos; Krisztina Moldovan; Adetokunbo Oyelese; Jared S Fridley; Ziya Gokaslan; Timothy J Kinsella; Jaroslaw T Hepel
Journal:  Adv Radiat Oncol       Date:  2018-04-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.